Biogen Opts To Retain Biosimilars Business

After Strategic Review, Firm Decides To ‘Optimize’ Its Interests In Biosimilars

 
• By Dave Wallace
  
Gloved hands holding syringe and vial with Biogen label
Biogen is holding on to its biosimilars interests • Source: Shutterstock

More from Strategy

More from Business